• 제목/요약/키워드: Dexamethasone treatment

검색결과 243건 처리시간 0.024초

NNNMU로 유도된 급성호흡곤란증후군 흰쥐 폐장에서의 dexamethasone에 의한 $PLA_2$, GGT의 활성도 및 형태학적인 변화 (Effects of high dose of dexamethasone on $PLA_2$, GGT activity and lung morphology in NNNMU-induced ARDS rats)

  • 이영만;박윤엽;고윤석
    • Tuberculosis and Respiratory Diseases
    • /
    • 제43권6호
    • /
    • pp.925-935
    • /
    • 1996
  • 연구목적: ARDS 발병기전의 일단을 알아보기 위하여 실험동물에서 ARDS와 같은 병변을 유도하는 N-nitroso-N-methylurethane(NNNMU)로 흰쥐에서 급성 폐손상을 유도하였다. ARDS에서의 제 II형 폐포세포의 기능 및 형태학적인 변화가 폐포강 내로의 단백질 이동과 관계 있다고 생각되므로 surfactant를 정량하고 동시에 gamma glutamyl transpeptidase(GGT)의 활성도를 측정하였다. 그리고 백혈구와 연관된 free radical의 역할을 알아보고자 phospholipase $A_2$ ($PLA_2$)의 활성도도 측정하였다. 이때 $PLA_2$의 inhibitor인 dexamethasone을 이용하여 $PLA_2$가 ARDS 발병에 미치는 영향을 알아보고자하였다. 방법: NNNMU에 의해 나타나는 폐부종의 확인을 위해 체중에 대한 폐장의 무게의 비를 계산하였고, 제 II형 폐포세포의 기능을 알아보기 위하여 surfactant의 양 및 GGT의 활성도를 측정하였다. 또한 염증세포의 침윤 및 제 II형 폐포세포의 형태학적인 변화를 광학 및 전자현미경을 이용하여 확인 하였으며 $PLA_2$의 활성도도 측정 하였다. 또한 이 모든 실험을 dexamethasone을 투여한 군에서도 시행하여 $PLA_2$의 억제로 나타나는 효과를 관찰하였다. 결과: NNNMU로 유도된 ARDS와 유사한 급성폐손상시 dexarnethasone은 폐부종을 감소시키고 GGT 및 $PLA_2$의 활성도를 감소시켰다. 형태학적으로는 염증세포 침윤의 감소가 관찰되었으며 병리학적인 소견도 호전시켰다. 결론: ARDS의 병인 중 $PLA_2$의 활성화가 염증세포의 침윤을 증가시키고 동시에 resprratory burst에 의한 free radical의 생성과 그 작용이 급성 폐손상의 중요한 기전으로 생각된다. 특히 $PLA_2$는 백혈구 세포막의 NADPH oxidase의 활성화에 따른 free radical의 생성뿐만 아니라 lipid medialor의 생성에도 관여하여 폐부종을 야기하는 중요한 요소가 되는데, 과량의 dexamethasone 은 $PLA_2$를 억제함으로써 이러한 변화를 감소시키는 것으로 생각된다.

  • PDF

Pooled Analysis of Pomalidomide for Treating Patients with Multiple Myeloma

  • Sun, Jia-Jia;Zhang, Chi;Zhou, Jun;Yang, Hui-Lin
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권8호
    • /
    • pp.3163-3166
    • /
    • 2015
  • Background: Patients with refractory or relapsed multiple myeloma are considered to have a very poor prognosis, and new regimens are needed to improve this setting. Pomalidomide is a new immunomodulatory drug with high in vitro potency. Immunomodulatory drugs are hypothesized to act through multiple mechanisms. Here we performed a systemic analysis to evaluate pomalidomide-based chemotherapy (pomalidomide in combination with low-dose dexamethasone) as salvage treatment for patients with refractory and relapsed multiple myeloma. Methods: Clinical studies evaluating the efffectiveness of pomalidomide based regimens on response and safety for patients with refractory and relapsed multiple myeloma were identified using a predefined search strategy. Pooled response rate (RR) of treatment were calculated. Results: For pomalidomide based regimens, 4 clinical studies which including 291 patients with refractory and relapsed multiple myeloma were considered eligible for inclusion. Systemic analysis suggested that, in all patients, pooled RR was 41.2% (120/291). Major adverse effects were hematologic toxicity, including grade 1 or 2 anemia, leucopenia and thrombocytopenia with pomalidomide based treatment. No treatment related death occurred. Conclusion: This pooled analysis suggests that pomalidomide in combination with low-dose dexamethasone is active with good tolerability in treating patients with refractory or relapsed multiple myeloma.

A Detrimental Role of Immunosuppressive Drug, Dexamethasone, During Clostridium difficile Infection in Association with a Gastrointestinal Microbial Shift

  • Kim, Hyeun Bum;Wang, Yuankai;Sun, Xingmin
    • Journal of Microbiology and Biotechnology
    • /
    • 제26권3호
    • /
    • pp.567-571
    • /
    • 2016
  • We investigated the increased risk of Clostridium difficile infection (CDI) caused by the combined use of antibiotics and an immunosuppressive drug in a mouse model. Our data showed that an approximate return to pretreatment conditions of gut microbiota occurred within days after cessation of the antibiotic treatment, whereas the recovery of gut microbiota was delayed with the combined treatment of antibiotics and dexamethasone, leading to an increased severity of CDI. An alteration of gut microbiota is a key player in CDI. Therefore, our data implied that immunosuppressive drugs can increase the risk of CDI through the delayed recovery of altered gut microbiota.

Effect of Picrorrhizae Rhizoma Aqueous Extracts on Paw Chronic Inflammation In Mice

  • Leem, Ji-Young;Ku, Sae-Kwang;Seo, Bu-Il;Jeon, Mi-Hye;Park, Ji-Ha
    • 대한한의학회지
    • /
    • 제36권2호
    • /
    • pp.21-35
    • /
    • 2015
  • Objectives: The purpose of this study was to examine the efficacy of Picrorrhizae Rhizoma (PR) aqueous extracts on the formalin-induced paw chronic inflammation in mice. Methods: PR extracts (500, 250 and 125mg/kg) or distilled water (DW) were orally administered once a day for 10 days to formalin-injected chronic inflammatory mice. The paw thicknesses and volumes were measured daily and the paw wet-weight and histological profiles were conducted at termination with paw tumor necrosis factor (TNF)-${\alpha}$ contents measurement. The anti-inflammatory effects of PR extracts were compared with dexamethasone. Results: In DW treated control group, the paw thickness, paw wet-weights and paw TNF-${\alpha}$ contents were markedly increased. Severe chronic inflammation signs such as severe fibrosis, the formation of necrotic debris, and infiltration of inflammatory cells were detected in histopathological observations. However, these formalin-induced changes were dramatically decreased by treatment of dexamethasone and all three different dosages of PR extracts. The anti-inflammatory effects of PR at highest dose were slighter than that of dexamethasone, but it did not show any harmful effects on the body weight contrary to dexamethasone. Conclusion: These results suggest that PR extracts have safe and favorable effects on formalin-induced chronic inflammation.

홍삼의 Dexamethasone 유도 근감소증 모델 백서에 대한 효과 연구 (The Effect of Red Ginseng on Sarcopenic Rat)

  • 서윤정;류재환
    • 대한한방내과학회지
    • /
    • 제39권6호
    • /
    • pp.1168-1180
    • /
    • 2018
  • Objective: As the number of sarcopenic patients worldwide is increasing, the need for the treatment of sarcopenia is increasing. Ginseng has been reported to be a major herbal supplement. We tested whether red ginseng would be effective for sarcopenia using red ginseng preparation which can be easily obtained locally in Korea. Methods: 30 rats were randomly divided into three groups: the control group (n=10) (Group C), the group with Dexamethasone -induced sarcopenia (n=10) (Group D), and the group to which red ginseng was administered group after induced sarcopenia with Dexamethasone (n=10) (Group DH). Dexamethasone was intraperitoneally administered to group D and group DH for 7 days to make sarcopenic model. After that, the red ginseng tablets prepared by Korea Ginseng Corporation were diluted in distilled water and administered orally to the DH group for 2 weeks. Body weight and grip strength were measured 8 times during the experiment. At the end of the experiment, blood was collected by cardiac puncture. In addition, the tibialis muscle was extracted, a myofibril cross section was measured by immunohistochemical staining and MyHC (myosin heavy chain) was quantified by Western blotting. Results: The ratio of the area on myofibril cross-section showed significant differences after administration of the red ginseng tablet. Conclusions: Red ginseng has a significant effect on the recovery of myofibril cross-section on sarcopenia. This experiment will be helpful for future clinical studies on drug effects in sarcopennia.

Dexamethasone으로 유도한 근감소 동물모델에서 상황버섯-오미자박 고상발효 열수추출물의 근감소 개선에 대한 효과 (Effect of water extract Phellinus linteus-discard Schisandra chinensis solid fermented extracts in an Animal Model of Dexamethasone-Induced Muscle Loss)

  • 황수진;김영숙;오태우
    • 대한한의학방제학회지
    • /
    • 제30권4호
    • /
    • pp.269-280
    • /
    • 2022
  • Objectives : In this study, it was investigated the effects of solid-phase fermentation extraction with Phellinus linteus of discarded Schisandra chinensis extract (PS) and its action mechanism on dexamethasone-induced muscle atrophy in mice. Methods : In mice, muscle atrophy model was induced by dexamethasone (5 mg/kg, I.p) once daily for 2 weeks and with PS extract administration (100 and 300 mg/kg, p.o.) as treatment groups. The changes in body weights, grip strength, Treadmill test, muscle weights, and the expression of atrophy-related genes were measured in muscle atrophy mice. The histological changes of gastrocnemius tissues were also observed by H&E staining with measurement of myofiber size. Results : The administration of PS extract increased significantly body weights, grip strength, treadmill test and muscle weights in muscle atrophy mice. PS extract administration increased significantly the area of myofibers and inhibited structural damages of muscle and increased significantly the expression of myogenin and decreased significantly the expression of MuRF1, Atrogin1 and phosphorylation of AMPK and PGC1α in muscle tissues of muscle atrophy mice. Conclusions : These results indicate that PS extract has a improvement effects on muscle atrophy with stimulation of myogenic differentiation and inhibition of mRNA degradation that could be related with the activation of AMPK and PGC1α signaling pathways in muscle. This suggests that PS extract can apply to treat muscle atrophy in clinics.

말초 혈액 단핵구에서 IL-8 발현에 관한 연구 (Study on IL -8 Expression in Peripheral Blood Monocytes)

  • 김재열;이재철;강민종;박재석;유철규;김영환;한성구;심영수;이재호
    • Tuberculosis and Respiratory Diseases
    • /
    • 제42권5호
    • /
    • pp.703-712
    • /
    • 1995
  • 연구배경: 말초혈액 단핵구는 정상적인 면역반응에 중요한 세포로서 탐식 기능과 항원 제공 기능외에 다양한 종류의 Cytokine을 생성하며, 이중 IL-8은 호중구에 대한 강력한 주화 작용과 직접적인 활성화 작용 등을 통해서 염증 작용을 증폭시키는 역할을 하는 것으로 알려져 었다. 따라서 IL-8 작용의 억제를 통하여 항염 효과를 기대할 수 있으며, 이러한 작용을 나타낼 것으로 기대되는 Dexamethasone, $PGE_2$, Indomethacin 및 IFN-$\gamma$를 이용하여 이러한 약제들이 말초혈액 단핵구에서 내독소 자극에 의한 IL-8의 생성 자극 효과에 어떤 영향을 미치는 지에 대해서 알아보았다. 방법: 말초혈액 단핵구는 자원자에게서 채취한 혈액을 Ficoll Hypaque density gradient method에 의해서 백혈구 층을 분리한 뒤에 플라스틱 접시에 부착함으로써 분리하였다. Dexamethasone, $PGE_2$, Indomethacin은 내독소로 자극하기 한 시간 전, 후에 처치하였고, IFN-$\gamma$는 내독소로 자극하기 한 시간 전에만 전처치 하였다. 내독소로 자극한 뒤 4시간 뒤에 RNA를 extraction한 뒤 Northern blot analysis를 시행하여 IL-8 mRNA를 분석하였고, 24시간 뒤에 ELISA를 통하여 IL-8 단백을 정량하였다. 이 과정을 3회 반복하여 다음과 같은 결과를 얻었다. 결과: 1) Dexamethasone의 전, 후 처치는 내독소 자극에 의한 IL-8 mRNA와 단백의 생성을 감소시켰다. 2) IFN-$\gamma$의 단독 투여는 내독소 자극을 받지 않은 군에서 IL-8 mRNA와 단백의 생성을 감소시켰다. 3) 내독소 투여 전에 IFN-$\gamma$를 전 처치 하였을 때, 내독소 단독 투여군에 비해 IL-8 mRNA 발현은 감소하였으나 IL-8 단백의 분비에는 차이가 없었다. 4) $PGE_2$와 Indomethacin은 각각 사용한 농도($10^{-6}M$, $10{\mu}M$)에서는 내독소 자극에 의한 IL-8 mRNA 및 단백의 생성에 별다른 영향을 미치지 못하였다. 결론: Dexamethasone은 말초혈액 단핵구에서 내독소의 자극에 의한 IL-8 mRNA 발현 및 단백의 생성을 억제함으로써 염증 반응을 억제할 것으로 기대된다.

  • PDF

Phosphoproteomic Analysis of AML14.3D10 Cell Line as a Model System of Eosinophilia

  • Ryu, Su-In;Kim, Won-Kon;Cho, Hyun-Ju;Lee, Phil-Young;Jung, Hye-Yun;Yoon, Tae-Sung;Moon, Jeong-Hee;Kang, Sung-Hyun;Poo, Ha-Ryoung;Bae, Kwang-Hee;Lee, Sang-Chul
    • BMB Reports
    • /
    • 제40권5호
    • /
    • pp.765-772
    • /
    • 2007
  • Eosinophils act as effectors in the inflammatory reactions of allergic diseases including atopic dermatitis. Atopic dermatitis patients and others with allergic disorders suffer from eosinophilia, an accumulation of eosinophils due to increased survival or decreased apoptosis of eosinophils. In this study, a differential phosphoproteome analysis of AML14.3D10 eosinophil cell line after treatment with IL-5 or dexamethasone was conducted in an effort to identify the phosphoproteins involved in the proliferation or apoptosis of eosinophils. Proteins were separated by 2-DE and alterations in phosphoproteins were then detected by Pro-Q Diamond staining. The significant quantitative changes were shown in nineteen phosphoproteins including retinoblastoma binding protein 7, MTHSP75, and lymphocyte cytosolic protein 1. In addition, seven phosphoproteins including galactokinase I, and proapolipoprotein, were appeared after treatment with IL-5 or dexamethasone. Especially, the phospho-APOE protein was down-regulated in IL-5 treated AML14.3D10, while the more heavily phosphorylated APOE form was induced after dexamethasone treatment. These phosphoproteome data for the AML14.3D10 cell line may provide clues to understand the mechanism of eosinophilia as well as allergic disorders including atopic dermatitis.

소풍산(消風散) 추출물이 수동 피부 아나팔락시스(1형 알러지 피부염)에 미치는 효과 (Effect of Sopung-san Extracts on the Passive Cutaneous Anaphylaxis of Wistar Rats (Type I Allergic Dermatitis))

  • 류지철;이재근;구세광;지선영
    • 한방안이비인후피부과학회지
    • /
    • 제22권3호
    • /
    • pp.1-10
    • /
    • 2009
  • Purpose : The objective of present study is to detect the effect of Sopungsan aqueous extracts (SPS) on the passive cutaneous anaphylaxis (PCA; type I allergic dermatitis) Method : 500, 250 and 125mg/kg of SPS were orally administered 12 hr-interval before antigen challenge (total 4 times administered). PCA reactions were induced using rat anti-ovalbumin (OVA) serum contain IgE (titer 1:32) as sensitization and OVA as antigen challenge. 30 min after antigen challenge, the diameter of blue-dye spots (evans blue) and leaked amount of dye were observed with histology and histomorphometry at the PCA induced sites. In addition, serum total IgE and histamine levels were also observed by ELISA, respectively. The effects of SPS were compared with dexamethasone 1mg/kg treated rats in the present study. Results : As results of PCA reaction, vasodilation related increase of diameter of blue-dye spot and amount of leaked dye were observed with swelling and edematous changes in the dermis of PCA induced sites. However, these changes on PCA reactions were dramatically and dose-dependently decreased by treatment of SPS as compared with vehicle control. In addition, serum elevations of IgE and histamine were also dose-dependently inhibited by treatment of SPS as compared with vehicle control respectively. The effects of SPS 500mg/kg were similar to that of dexamethasone 1mg/kg in the present study. Conclusion : Base on the results of the present study, it is concluded that SPS has favorable effect on the PCA-induced allergic dermatitis, and SPS 500mg/kg showed similar favorable effects as compared with dexamethasone 1mg/kg. The present findings demonstrate that SPS can be effective for the prevention and treatment of allergic dermatitis.

  • PDF

구강편평태선에 대한 스테로이드 가글의 효과비교 연구 (The Effects of Corticosteroid Solutions in OLP Patients)

  • 정성희;박수현;옥수민;허준영;고명연;안용우
    • Journal of Oral Medicine and Pain
    • /
    • 제37권1호
    • /
    • pp.27-33
    • /
    • 2012
  • 피부와 구강점막에서 발견되는 편평태선은 만성 염증성 질환으로 세포매개성 면역반응이 주로 언급되고 있으나 아직 정확한 원인은 밝혀지지 않았다. 따라서 완전한 치료법은 아직 없으며 증상의 완화를 치료목표로 하고 있다. 본 연구에서는 구강편평태선의 일차적인 치료법으로 사용되는 corticosteroid의 두 가지 가글용액의 효과를 비교하였다. 2002년부터 2010년까지 부산대학교 치과병원 구강내과에서 구강편평태선으로 진단받은 환자들 중 corticosteroid 가글용액을 처방받은 환자들 총 180명의 환자기록을 조사하였다. 사용된 두 종류의 가글용액은 각각 dexamethasone(dexamethasone disodium phosphate, 0.05%)과 prednisolone($solondo^{(R)}$)을 포함하는 용액이었으며 약물 사용 후 증상의 완화 및 재발의 시기를 기록하여 분석하였다. Dexamethasone gargle(dexa gargle) 처방군은 33명(여성 25명, 남성 8명), prednisolone gargle(solon gargle)처방군은 147명(여성 114명, 남성 33명)이었으며 환자군의 평균연령대는 50대였다. 약물투여 후 초기 2주이내에 증상이 호전된 경우는 dexa gargle을 사용한 환자군에서 유의성 있게 나타났으나 증상재발의 경우는 두가지 가글용액의 차이가 나타나지 않았다. 구강편평태선 환자에 대한 도포용 스테로이드 가글을 이용한 치료에서 증상의 빠른 호전을 기대하기 위해서는 solon gargle보다는 dexa gargle을 사용할 수 있으나 재발율에 있어서는 두 약물의 차이가 발견되지 않았다.